- Home
- SAGE vs ATEX Comparison
SAGE vs ATEX Comparison
Compare SAGE & ATEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- ATEX
- Stock Information
- Founded
- SAGE 2010
- ATEX 1997
- Country
- SAGE United States
- ATEX United States
- Employees
- SAGE N/A
- ATEX N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- ATEX Telecommunications Equipment
- Sector
- SAGE Health Care
- ATEX Telecommunications
- Exchange
- SAGE Nasdaq
- ATEX Nasdaq
- Market Cap
- SAGE 571.1M
- ATEX 468.9M
- IPO Year
- SAGE 2014
- ATEX N/A
- Fundamental
- Price
- SAGE $9.12
- ATEX $22.79
- Analyst Decision
- SAGE Hold
- ATEX Buy
- Analyst Count
- SAGE 18
- ATEX 2
- Target Price
- SAGE $9.89
- ATEX $64.00
- AVG Volume (30 Days)
- SAGE 1.8M
- ATEX 228.1K
- Earning Date
- SAGE 07-30-2025
- ATEX 08-05-2025
- Dividend Yield
- SAGE N/A
- ATEX N/A
- EPS Growth
- SAGE N/A
- ATEX N/A
- EPS
- SAGE N/A
- ATEX N/A
- Revenue
- SAGE $47,404,000.00
- ATEX $6,031,000.00
- Revenue This Year
- SAGE $101.71
- ATEX $5.17
- Revenue Next Year
- SAGE $42.30
- ATEX $2.92
- P/E Ratio
- SAGE N/A
- ATEX N/A
- Revenue Growth
- SAGE N/A
- ATEX 43.90
- 52 Week Low
- SAGE $4.62
- ATEX $22.50
- 52 Week High
- SAGE $13.47
- ATEX $42.91
- Technical
- Relative Strength Index (RSI)
- SAGE 66.62
- ATEX 26.78
- Support Level
- SAGE $9.10
- ATEX $22.67
- Resistance Level
- SAGE $9.36
- ATEX $24.81
- Average True Range (ATR)
- SAGE 0.10
- ATEX 0.79
- MACD
- SAGE -0.09
- ATEX -0.15
- Stochastic Oscillator
- SAGE 29.69
- ATEX 6.73
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About ATEX Anterix Inc.
Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.